Treatment of fatty liver disease of varied etiology: current guidelines
Essential phospholipids (EP) preparations are the mainstay of the therapy for alcoholic and non-alcoholic fatty liver disease. Efficacy of soya-bean phospholipids preparation Resalut® was demonstrated in moderate and severe chronic alcoholic steatohepatitis. Unlike other EP-based preparations, Resalut® contains no colouring agents, flavours and preservatives. Resalut® is characterized by hepatoprotective, cholesterol lowing activity, is well-tolerated and improves patients’ quality of life.